Summary
The photosensitizing properties of m-tetrahydroxyphenylchlorin (mTHPC) and polyethylene glycol-derivatized mTHPC (pegylated mTHPC) were compared in nude mice bearing human malignant mesothelioma, squamous cell carcinoma and adenocarcinoma xenografts. Laser light (20 J/cm2) at 652 nm was delivered to the tumour (surface irradiance) and to an equal-sized area of the hind leg of the animals after i.p. administration of 0.1 mg/kg body weight mTHPC and an equimolar dose of pegylated mTHPC, respectively. The extent of tumour necrosis and normal tissue injury was assessed by histology. Both mTHPC and pegylated mTHPC catalyse photosensitized necrosis in mesothelioma xenografts at drug-light intervals of 1–4 days. The onset of action of pegylated mTHPC seemed slower but significantly exceeds that of mTHPC by days 3 and 4 with the greatest difference being noted at day 4. Pegylated mTHPC also induced significantly larger photonecrosis than mTHPC in squamous cell xenografts but not in adenocarcinoma at day 4, where mTHPC showed greatest activity. The degree of necrosis induced by pegylated mTHPC was the same for all three xenografts. mTHPC led to necrosis of skin and underlying muscle at a drug-light interval of 1 day but minor histological changes only at drug-light intervals from 2–4 days. In contrast, pegylated mTHPC did not result in histologically detectable changes in normal tissues under the same treatment conditions at any drug-light interval assessed. In this study, pegylated mTHPC had advantages as a photosensitizer compared to mTHPC.
Tissue concentrations of mTHPC and pegylated mTHPC were measured by high-performance liquid chromatography in non-irradiated animals 4 days after administration. There was no significant difference in tumour uptake between the two sensitizers in mesothelioma, adenocarcinoma and squamous cell carcinoma xenografts. Tissue concentration measurements were of limited use for predicting photosensitization in this model.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Allémann, E., Brasseur, N., Benrezzak, O., Rousseau, J., Kudrevich, S. V., Boyle, R. W., Leroux, J. C., Gurny, R. & Van Lier, J. E. (1995). PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to emt-6 mouse mammary tumours. J Pharm Pharmacol 47: 382–387.
Alian, W., Andersson-Engels, S., Svanberg, K. & Svanberg, S. (1994). Laser-induced fluorescence studies of meso-tetra (hydroxyphenyl) chlorin in malignant and normal tissues in rats. Br J Cancer 70: 880–885.
Altermatt, H. J., Gebbers, J. O. & Laissue, J. A. (1988). Heavy water delays growth of human carcinoma in nude mice. Cancer 62: 462–466.
Ash, D. V. & Brown, S. B. (1993). New drugs and future developments in photodynamic therapy. Eur J Cancer 29A: 1781–1783.
Berenbaum, M. C., Bonnett, R. & Scourides, P. A. (1982). In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer 45: 571–581.
Bonnett, R. & Berenbaum, M. C. (1989). Porphyrins as sensitizers. In Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use, Ciba Foundation Symposium 146, pp. 40–53. John Wiley: Chichester
Burnham, N. L. (1994). Polymers for delivering peptides and proteins. Am J Hosp Pharm 51: 210–218.
Gibson, S. L., Foster, T. H., Feins, R. H., Raubertas, R. F., Fallon, M. A. & Hilf, R. (1994). Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br J Cancer 69: 473–481.
Houghton, J. A. & Houghton, P. J. (1987). The suitability and use of human tumor xenografts. In Rodent Tumor Models in Experimental Cancer Therapy, Kallman RF (ed), pp. 199–204. Pergamon Press: Oxford
Ji, Y., Powers, S. K., Brown, J. T., Walstad, D. & Maliner, L. (1994). Toxicity of photodynamic therapy with photofrin in the normal rat brain. Lasers Surg Med 14: 219–228.
Levy, J. G. (1994). Photosensitizers in photodynamic therapy. Semin Oncol 21: 4–10.
Lofgren, L. A., Ronn, A. M., Abramson, A. L., Shikowitz, M. J., Nouri, M., Lee, C. J., Bati, J. & Steinberg, B. M. (1994). Photodynamic therapy using m-tetra-(hydroxyphenyl)chlorin. An animal model. Arch Otolaryngol Head Neck Surg 120: 1355–1362.
Ma, L., Moan, J. & Berg, K. (1994). Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int J Cancer 57: 883–888.
Pass, H. I., De Laney, T. F., Tochner, Z., Smith, P. E., Temeck, B. K., Pogrebniak, H. W., Kranda, K. C., Russo, A., Friauf, W. F., Cole, J. W., Mitchell, J. B. & Thomas, G. (1994). Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol 1: 28–37.
Pelton, J. J., Kovalyshin, M. J. & Keller, S. M. (1992). Intrathoracic organ injury associated with photodynamic therapy. J Thoracic Cardiovasc Surg 103: 1218–1223.
Peng, Q., Moan, J., Ma, L. W. & Wesland, J. M. (1995). Uptake, localization and photodynamic effect of mTHPC in normal and tumor tissue of mice bearing mammary carcinoma. Cancer Res 55: 2620–2626.
Reale, F. R., Griffin, T. W., Compton, J. M., Graham, S., Townes, P. L. & Bogden, A. (1987). Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model. Cancer Res 47: 3199–3205.
Ris, H. B., Altermatt, H. J., Inderbitzi, R., Hess, R., Nachbur, B., Stewart, J. C. M., Bonnet, R., Berenbaum, M. C. & Althaus, U. (1991). Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer 64: 1116–1120.
Ris, H. B., Altermatt, H. J., Nachbur, B., Stewart, J. C. M., Wang, Q., Lim, C. K., Bonnet, R. & Althaus, U. (1993a). Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma. Int J Cancer 53: 141–146.
Ris, H. B., Altermatt, H. J., Stewart, J. C. M., Schaffner, T., Wang, Q., Lim, C. K., Bonnet, R. & Althaus, U. (1993b). Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: optimization of the therapeutic ratio. Int J Cancer 55: 245–249.
Stewart, F. A. & Oussoren, Y. (1993). Functional and histological bladder damage in mice after photodynamic therapy: the influence of sensitiser dose and time of administration. Br J Cancer 68: 673–677.
Takita, H., Mang, T. S., Loewen, G. M., Antkowiak, J. G., Raghavan, D., Grajek, J. R. & Dougherty, T. J. (1994). Operation and intracavitary photodynamic therapy for malignant mesothelioma: a phase II study. Ann Thorac Surg 58: 995–998.
Tochner, Z. A., Pass, H. I., Smith, P. D., Delaney, T. F., Sprague, M., Deluca, A. M., Harrington, F., Thomas, G. F., Terrill, R., Bacher, J. D. & Russo, A. (1994). Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early clinical experience. Lasers Surg Med 14: 118–123.
Van Geel, I. P., Oppelaar, H., Oussoren, Y. G., Van Der Valk, M. A. & Stewart, F. A. (1995). Photosensitizing efficacy of mTHPC-PDT compared to Photofrin-PDT in the RIF1 mouse tumour and normal skin. Int J Cancer 60: 388–394.
Veenhuizen, R. B., Ruevekamp-Helmers, M. C., Helmerhorst, T. J., Kenemans, P., Mool, W. J., Marijnissen, J. P. & Stewart, F. A. (1994). Intraperitoneal photodynamic therapy in the rat comparison of toxicity profiles for photofrin and mTHPC. Int J Cancer 59: 830–836.
Author information
Authors and Affiliations
Additional information
Department of Chemistry, Queen Mary and Westfield College, London, UK
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ris, HB., Krueger, T., Giger, A. et al. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts. Br J Cancer 79, 1061–1066 (1999). https://doi.org/10.1038/sj.bjc.6690170
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690170
Keywords
This article is cited by
-
Optical and Opto-Acoustic Interventional Imaging
Annals of Biomedical Engineering (2012)